SCHEMBL6950320

SCHEMBL6950320

Cc1nccn1CCCC(=O)c1ccc(F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
HTR7 P34969 2/20 0.51
TSHR P16473 1/20 0.51
HTR1A P08908 3/20 0.51
DRD3 P35462 3/20 0.51
DRD2 P14416 2/20 0.51
DRD4 P21917 2/20 0.51
HTR2A P28223 2/20 0.51
HTR2C P28335 2/20 0.51
ADRA2C P18825 1/20 0.51
HRH1 P35367 1/20 0.51
NAMPT P43490 1/20 0.49
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
CHRM2 P08172 1/20 0.49
ADRA2A P08913 1/20 0.49
DRD1 P21728 1/20 0.49
ADRA1A P35348 1/20 0.49
OPRM1 P35372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6948828 0.86 ALDH1A1 (0.51) KMT2AALDH1A1POLBLMNACYP1A2
SCHEMBL7080414 0.86 HDAC1 (0.47) DRD2KMT2AKCNH2ALDH1A1POLB
SCHEMBL7561381 0.83 NOS1 (0.67) NPC1RAB9ATSHRNAMPTALDH1A1
SCHEMBL11144610 0.81 MMP1 (0.46) NPC1KMT2AMEN1ALDH1A1POLB
SCHEMBL6943126 0.78 ALDH1A1 (0.50) NPC1RAB9ATSHRKMT2AKCNH2
SCHEMBL6947633 0.77 ESR1 (0.52) HTR1AKMT2AALDH1A1POLBNOS1
SCHEMBL26488900 0.76 ALDH1A1 (0.61) TSHRKMT2AALDH1A1POLBSMN1; SMN2
SCHEMBL6943140 0.76 MAPT (0.56) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL6953959 0.74 SLC6A4 (0.58) DRD2DRD4NAMPTKMT2AMEN1
Hydrochloric Acid SCHEMBL6952909 0.74 SLC6A4 (0.57) DRD2DRD4NAMPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP disclosed
US-5770740-A TREATING DEPRESSION AND OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1998-06-23 US disclosed
US-5696142-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-12-09 US disclosed
US-5686447-A ANTIDEPRESSANTS, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5686483-A TREATING DEPRESSION AND OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5686446-A ANTIDEPRESSANTS, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5684021-A Aminoalkyloximes for treating depression and affective disorders HOECHST MARION ROUSSEL, INC. (US) 1997-11-04 US disclosed
US-5665756-A Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders HOECHST MARION ROUSSEL, INC. (US) 1997-09-09 US disclosed
US-5648367-A ANTIDEPRESANTS, OBSESSIVE-COMPULSIVE DISORDER HOECHST MARION ROUSSEL, INC. (US) 1997-07-15 US disclosed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP disclosed